Submit a tip
Do you have info to share with HuffPost reporters? Here’s how.
Contributor
Professor Hardev Pandha
Director, Surrey Cancer Research Institute, University of Surrey, Consultant in Medical Oncology, St Luke's Cancer Centre, Guildford, UK
Prof Hardev Pandha FRCP FRACP PhD FSB
Director, Surrey Cancer Research Institute, University of Surrey,Consultant in Medical Oncology, St Luke's Cancer Centre, Guildford, UK
Cancer immunotherapy using cancer-seeking (oncolytic) viruses. He is a clinician scientist who trained in internal medicine and subsequently in medical oncology at Hammersmith Hospital and at the Royal Marsden Hospital, London. He completed his PhD in the CRUK labs at the Hammersmith. He was a senior lecturer in tumour immunology at St Georges, University of London in 2000 before being appointed Prof of Urological Oncology at the University of Surrey in 2007. His research focus centres on the development and clinical evaluation of cancer immunotherapy, gene and viral therapy and targeted agents.